MET
Price
$85.58
Change
-$0.27 (-0.31%)
Updated
Jun 18 closing price
Capitalization
55.07B
46 days until earnings call
Intraday BUY SELL Signals
PUK
Price
$26.79
Change
-$0.00 (-0.00%)
Updated
Jun 18 closing price
Capitalization
33.56B
Intraday BUY SELL Signals
Interact to see
Advertisement

MET vs PUK

MET vs PUK Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MET vs. PUK commentary
Jun 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MET is a Hold and PUK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 20, 2026
Stock price -- (MET: $85.58 vs. PUK: $26.79)
Brand notoriety: MET: Notable vs. PUK: Not notable
Both companies represent the Life/Health Insurance industry
Current volume relative to the 65-day Moving Average: MET: 234% vs. PUK: 119%
Market capitalization -- MET: $55.07B vs. PUK: $33.56B
MET [@Life/Health Insurance] is valued at $55.07B. PUK’s [@Life/Health Insurance] market capitalization is $33.56B. The market cap for tickers in the [@Life/Health Insurance] industry ranges from $154.94B to $0. The average market capitalization across the [@Life/Health Insurance] industry is $17.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MET’s FA Score shows that 3 FA rating(s) are green whilePUK’s FA Score has 0 green FA rating(s).

  • MET’s FA Score: 3 green, 2 red.
  • PUK’s FA Score: 0 green, 5 red.
According to our system of comparison, MET is a better buy in the long-term than PUK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MET’s TA Score shows that 4 TA indicator(s) are bullish while PUK’s TA Score has 6 bullish TA indicator(s).

  • MET’s TA Score: 4 bullish, 5 bearish.
  • PUK’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PUK is a better buy in the short-term than MET.

Price Growth

MET (@Life/Health Insurance) experienced а -2.28% price change this week, while PUK (@Life/Health Insurance) price change was +2.88% for the same time period.

The average weekly price growth across all stocks in the @Life/Health Insurance industry was +0.69%. For the same industry, the average monthly price growth was +2.30%, and the average quarterly price growth was +0.96%.

Reported Earning Dates

MET is expected to report earnings on Aug 05, 2026.

Industries' Descriptions

@Life/Health Insurance (+0.69% weekly)

Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MET($55.1B) has a higher market cap than PUK($33.6B). MET has higher P/E ratio than PUK: MET (16.55) vs PUK (8.73). MET YTD gains are higher at: 10.024 vs. PUK (-12.774). PUK has less debt than MET: PUK (5.33B) vs MET (21.1B). MET has higher revenues than PUK: MET (76B) vs PUK (27.4B).
METPUKMET / PUK
Capitalization55.1B33.6B164%
EBITDAN/AN/A-
Gain YTD10.024-12.774-78%
P/E Ratio16.558.73190%
Revenue76B27.4B277%
Total Cash121BN/A-
Total Debt21.1B5.33B396%
FUNDAMENTALS RATINGS
MET vs PUK: Fundamental Ratings
MET
PUK
OUTLOOK RATING
1..100
1211
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
50
Fair valued
PROFIT vs RISK RATING
1..100
40100
SMR RATING
1..100
9654
PRICE GROWTH RATING
1..100
2762
P/E GROWTH RATING
1..100
3087
SEASONALITY SCORE
1..100
3750

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MET's Valuation (31) in the Life Or Health Insurance industry is in the same range as PUK (50) in the Multi Line Insurance industry. This means that MET’s stock grew similarly to PUK’s over the last 12 months.

MET's Profit vs Risk Rating (40) in the Life Or Health Insurance industry is somewhat better than the same rating for PUK (100) in the Multi Line Insurance industry. This means that MET’s stock grew somewhat faster than PUK’s over the last 12 months.

PUK's SMR Rating (54) in the Multi Line Insurance industry is somewhat better than the same rating for MET (96) in the Life Or Health Insurance industry. This means that PUK’s stock grew somewhat faster than MET’s over the last 12 months.

MET's Price Growth Rating (27) in the Life Or Health Insurance industry is somewhat better than the same rating for PUK (62) in the Multi Line Insurance industry. This means that MET’s stock grew somewhat faster than PUK’s over the last 12 months.

MET's P/E Growth Rating (30) in the Life Or Health Insurance industry is somewhat better than the same rating for PUK (87) in the Multi Line Insurance industry. This means that MET’s stock grew somewhat faster than PUK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
METPUK
RSI
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
57%
Momentum
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
52%
MACD
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
52%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
50%
Bearish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 8 days ago
63%
Bullish Trend 5 days ago
59%
Declines
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 3 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bullish Trend 2 days ago
48%
Bearish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
MET
Daily Signal:
Gain/Loss:
PUK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TGEN6.030.25
+4.33%
Tecogen Inc
PYPL42.510.43
+1.02%
PayPal Holdings
BELFA265.770.11
+0.04%
Bel Fuse
CRTO17.44-0.05
-0.29%
Criteo SA
PHIO1.03-0.05
-4.63%
Phio Pharmaceuticals Corp

MET and

Correlation & Price change

A.I.dvisor indicates that over the last year, MET has been closely correlated with PRU. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if MET jumps, then PRU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MET
1D Price
Change %
MET100%
-0.31%
PRU - MET
72%
Closely correlated
-0.45%
LNC - MET
71%
Closely correlated
-0.59%
CNO - MET
67%
Closely correlated
-0.78%
JXN - MET
64%
Loosely correlated
-1.46%
PRI - MET
57%
Loosely correlated
+0.16%
More